← Back to headlines
Eli Lilly to Acquire Psychedelic Drugmaker AtaiBeckley for $2.8 Billion
Eli Lilly has announced its intention to acquire AtaiBeckley, a psychedelic drugmaker, in a deal valued at $2.8 billion, signaling a significant move into the emerging field of psychedelic therapeutics.
16 Jul, 11:10 — 16 Jul, 11:10
Sources
Showing 1 of 1 sources
